IL10 and cancer: Under the hypoxic conditions generated by rapid tumor cell proliferation, TAMs predominantly shift toward the M2 phenotype and upregulate IL‐10, VEGF, and HIF‐1α, contributing to cancer metastasis and an increasingly immunosuppressive TME.